NCT02944461View on ClinicalTrials.gov

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 11, 2017

Conditions
Acne
Interventions
DRUG

Dapsone 7.5 % gel

Dapsone gel 7.5% applied once daily to truncal acne

Trial Locations (3)

40014

DermResearch, PLLC, Louisville

89117

James Q. DelRosso DO, LLC, Las Vegas

95819

Dermatology and Laser Surgery, Sacramento

Sponsors
All Listed Sponsors
lead

Derm Research, PLLC

OTHER

NCT02944461 - Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris | Biotech Hunter | Biotech Hunter